Highlights for this year include:
- Form a holistic and practical UPC litigation strategy with a cross-industry case law review, a mock trial alongside leading judges and litigators and a pharma and biotech UPC strategy panel.
- Update your pharma and biotech patent litigation strategy with the latest regulatory developments and case law regarding the doctrine of equivalents, second medical use, preliminary injunctions and divisional patent practice.
- Develop a transatlantic understanding of patentability concerns with an Amgen vs Sanofi case law review and an industry-panel concerning the G2/21 EPO Board of Appeals decision.
- Form a global understanding of the patent litigation ecosphere with a panel of judges from the UK, EPO, USA and the UPC.
For more information and to register, see the Pharma & Biotech Patent Litigation Europe website.